Eficácia do oclacitinib no manejo da síndrome da atopia felinaipt / Efficacy of oclacitinib on feline atopic syndrome managementien
Fernandes, Keylla Suellen Batalha Rocha; Ferreira, Milla Baracho1Universidade Federal Rural do Semi-Árido2Hospital VeterináriocMossorópBrasil; Silva, Alessandra Moreira da1Universidade Federal Rural do Semi-Árido2Hospital VeterináriocMossorópBrasil; Marques, Kayana Cunha1Universidade Federal Rural do Semi-Árido2Hospital VeterináriocMossorópBrasil; Rocha, Brizza Zorayd Luz Lopes1Universidade Federal Rural do Semi-Árido2Hospital VeterináriocMossorópBrasil; Bezerra, José Artur Brilhante1Universidade Federal Rural do Semi-Árido2Hospital VeterináriocMossorópBrasil; Filgueira, Kilder Dantas1Universidade Federal Rural do Semi-Árido2Hospital VeterináriocMossorópBrasil.
Acta sci. vet. (Impr.);
47(suppl.1): Pub.374-2019. ilus
Artigo
em Português
| VETINDEX
| ID: biblio-1458137
Resumo
Background:The feline atopic syndrome (FAS) associated to environmental allergens is the third most common allergic dermatosis in domestic cats. In general, clinical signs are not pathognomonic and the exclusion of other pruritus causes is necessary to reach the diagnosis of FAS. The treatment is based on the use of drugs to control the pruritus, such as glucocorticoids, cyclosporine and, recently, oclacitinib, a Janus kinase inhibitor. This study aimed to report the efficacy of oclacitinib on the treatment of FAS associated to environmental allergens. Case:A 10-year-old female feline, crossbred, presented a history of pruritic dermatitis during ten months and diarrhea. The animal had been submitted to treatment for ectoparasites with pour-on selamectin and was fed with a commercial hypoallergenic diet in the last eight weeks or so. However, no improvement on the skin condition was observed. Physical examination revealed disseminated furfuraceous desquamation, excoriation and erythema on the right supraorbital region. Bilateral conjunctivitis was also observed. Complete blood cell count, biochemistry profile, urinalysis, immunochroma-thographic test for feline immunodeffiency virus (FIV) and feline leukemia virus (FeLV), fungic culture and abdominal ultrasonography were requested. The abnormalities observed were reduced urinary density and discrete loss of renal corticomedullary differentiation. Thus, based on physical examination and complementary exams, the animal was diag-nosis with FAS, since the main other causes of pruritus (hypersensitivity to ectoparasites and alimentary allergens) were excluded. The animal was also diagnosed with stage 1 chronic kidney disease. Therapy based on oclacitinib was instituted with an induction dose of 1 mg/kg twice daily for 14 days, followed by a maintenance dose of 1 mg/kg once daily. After 30 days of treatment, a satisfactory therapeutic response was observed, with complete remission of pruritus. The...
Biblioteca responsável:
BR68.1
Texto completo